Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988
A Details of director or officer
Name of director or officer of public issuer: Gordon MacLeod
Name of public issuer: Ryman Healthcare Ltd
Name of related body corporate (if applicable):
Position held in public issuer: Chief Financial Officer & Company Secretary
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 1) 174,842 Ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities: 2) Beneficial Owner subject
to the terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme
Name of registered holder of those securities 3) Gordon Neil MacLeod
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 4) N/a
Consideration paid for acquisition: 5) N/a
If the relevant interest was disposed of--
Date of disposal: 6) 30 December 2011
Consideration received for disposal: 7) $472,073.40 (or $2.70 per share)
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: 8) On market sale subject to the loan
repayment terms of the Ryman Healthcare Ltd Employee Share Purchase Scheme.
Mr MacLeod retains a beneficial interest in 420,800 shares subject to the
same scheme.
E Total number of transactions this notice relates to: 9) One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10) 18 August 2011
G Signature
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Gordon MacLeod
Date of signature: 4 January 2012
Name and title of authorised person: Gordon MacLeod, CFO & Company Secretary
Notes:
Use this form to disclose all the acquisitions and disposals by a director or
officer of a public issuer of relevant interests in securities of the public
issuer or of a related body corporate. The disclosure must normally be made
within 5 trading days of the first acquisition or disposal disclosed in this
notice
"Provide the information required under headings C and D for each type of
security identified under heading B."
"This notice must be signed either by the director or officer making the
disclosure, or by a person authorised by the director or officer to sign on
his or her behalf."
References
1. Regulation 8.
2. Regulation 7.
3. Regulation 7.
4. Regulation 9.
5. Regulation 10.
6. Regulation 9.
7. Regulation 10.
8. Regulation 11.
9. Regulation 12 (2)
10. Regulation 13.
11. Regulation 14.
End CA:00218264 For:RYM Type:RELINT Time:2012-01-04 14:04:31